☆ 4.7 Editorial Material

Factors for the recurrence of hepatocellular carcinoma after hepatic resection

JOURNAL OF GASTROENTEROLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis

Hisashi Nakayama et al.

Summary: This study examined the effect of blood product transfusion on the prognosis of patients who underwent hepatectomy for hepatocellular carcinoma. The results showed that transfusion groups had lower tumor recurrence rate and overall survival rate compared to non-transfusion groups. Red blood cell transfusion negatively impacts the recurrence and long-term survival of hepatocellular carcinoma.

JOURNAL OF GASTROENTEROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Dynamic risk profiling of HCC recurrence after curative intent liver resection

Tommy Ivanics et al.

Summary: We evaluated the natural progression, pattern, and timing of various disease states after liver resection for HCC using multistate modeling and created a practical calculator to provide prognostic information for patients and clinicians.

HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents

Yuya Seko et al.

Summary: The eradication of hepatitis C virus (HCV) before molecular-targeted agent (MTA) therapy in hepatocellular carcinoma (HCC) patients was found to maintain liver function, prolong treatment period, and improve overall survival.

JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis

Yuki Tahata et al.

Summary: DAA therapy can improve the sustained virologic response rate in patients with cirrhosis. However, in patients with decompensated cirrhosis, the occurrence of hepatocellular carcinoma and liver-related events, as well as the mortality rate, are higher.

JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection

Xiao-Hui Wang et al.

Summary: This study assessed the impact of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on the prognosis of patients with hepatocellular carcinoma (HCC) related to hepatitis B virus (HBV). The results showed that TDF treatment had significantly better overall survival and better protection of liver function compared to ETV treatment, but there was no difference in the incidence of HCC recurrence between the two.

JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Article Oncology

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy

Tongdi Fang et al.

Summary: The study found that splenic volume is the only predictor of late recurrence in hepatocellular carcinoma (HCC), and it is associated with portal hypertension and liver cirrhosis.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Virology

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection

Shih-Chieh Chien et al.

Summary: This study found that patients with NASH-related HCC had earlier tumor recurrence after curative resection compared to patients with virus-related HCC. Post-surgical surveillance is crucial for detecting early recurrence in patients with NASH-related HCC.

VIRUSES-BASEL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

Hironori Ochi et al.

Summary: DAAs treatment after HCC can prevent hepatic functional reserve deterioration and significantly improve both recurrence and survival rates. This study showed that in patients receiving DAAs treatment, the 48-month survival rate was 91.0% and the recurrence rate was 36.7%, both significantly better than in patients not receiving DAAs treatment.

JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Masatoshi Kudo et al.

Summary: The Clinical Practice Manual for Hepatocellular Carcinoma is based on evidence and expert consensus, focusing on pathology, diagnosis, and treatment. Different from the JSH Clinical Practice Guidelines, this manual emphasizes practicality and is written by a panel of experts from the JSH.

LIVER CANCER (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study

Darrick K. Li et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy

Yuko Nagaoki et al.

PLOS ONE (2017)

添加到收藏夹

Article Surgery

Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis

Parissa Tabrizian et al.

ANNALS OF SURGERY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Resection of hepatocellular cancer ≤2 cm: Results from two Western centers

Sasan Roayaie et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection

Tetsuya Hosaka et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Anesthesiology

Risk factors for postoperative mortality and morbidities in emergency surgeries

Tomonori Matsuyama et al.

JOURNAL OF ANESTHESIA (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.